Lymphangitic carcinomatosis
Updates to Synonym Attributes
Updates to Article Attributes
Lymphangitic carcinomatosis, or lymphangitis carcinomatosa, is the term given to tumour spread through the lymphatics of the lung, and is most commonly seen secondary to adenocarcinoma.
Epidemiology
The demographics will reflect that of the underlying malignancy (see below).
Clinical presentation
Clinical presentation is variable. Some patients experience dyspnoea and abnormal pulmonary function tests early in the course of the disease, well before any radiographic abnormalities are evident, whereas others remain asymptomatic until much later 4.
Pathology
Lymphangitis carcinomatosaLymphangitic carcinomatosis is most commonly seen secondary to adenocarcinomas such as:
- breast cancer: most common 3
- lung cancer (bronchogenic adenocarcinoma)
- colon cancer
- stomach cancer
- prostate cancer
- cervical cancer
- thyroid cancer
It can also be seen in numerous other primary cancers, e.g. laryngeal cancer, pancreatic cancer, etc.
A helpful mnemonic for lymphangitic carcinomatosis is sometimes used for its common causes.
Mechanism
Spread into the lymphatics in most cases (except in bronchogenic adenocarcinoma) usually occurs following haematogenous seeding of the lungs, with subsequent lymphatic involvement 1, 3,3. It may also occur by retrograde spread into the lymphatics from the mediastinal and hilar lymph nodes.
Both the peripheral lymphatics coursing in the interlobular septa and beneath the pleura, and the central lymphatics coursing in the bronchovascular interstitium are involved 2.
Histologically tumour is seen both within lymphatics and in the adjacent interstitium, with associated oedema and desmoplasia 3, 4,4.
Radiographic features
Radiographic appearances can most easily be divided into those due to the involvement of the peripheral (interlobular septae) and central lymphatic system. Involvement may be diffusely of both, or predominantly of one compartment or the other compartment 4. Distribution of changes is variable, but most are asymmetric and patchy 3. It is usually bilateral but may be unilateral, especially in cases of lung and breast cancer.
Plain radiograph
Unfortunately up to a quarter of patients with subsequently established lymphangitic carcinomatosis have normal chest x-rays 2. When abnormal, the most common finding is of a reticulonodular pattern, with thickening of the interlobular septae which may resemble Kerley B lines.
CT
CT, especially HRCT, is excellent at demonstrating both peripheral and central changes.
Typically the appearance is that of interlobular septal thickening, most often nodular and irregular, although smooth thickening may also sometimes be seen 1-4. This results in a prominent definition of the secondary pulmonary lobules, manifesting as tessellating polygons.
Thickening of the bronchovascular interstitium is usually irregular and nodular, with changes seen extending towards the hilum 4.
The combination may give a characteristic "dot in box" appearance.
Additional HRCT findings include 2, 4:
- subpleural nodules, and thickening on the interlobar fissures
- pleural effusion(s): pleural carcinomatosis
- hilar and mediastinal nodal enlargement (40-50%)
- relatively little destruction of overall lung architecture
A helpful sign is that the overall lung and lobular architecture is preserved 1. In most cases, lymphangitic carcinomatosis progresses rapidly and patients deteriorate (see treatment and prognosis below), however in some cases changes may remain stable over considerable time 3. As such a 'stable' appearance when compared to previous imaging does not necessarily exclude the diagnosis.
Treatment and prognosis
Treatment is determined by the histology of the primary tumour, but in general, relies on systemic chemotherapy.
Prognosis of patients with lymphangitic carcinomatosis is poor, with approximately half of patients having succumbedsuccumbing to their illness within a year of diagnosis 2, 3. Occasionally long term, long-term survival is encountered 3.
Differential diagnosis
Considerations include a differential for that of thickened interlobular septae, with common entities comprising of 1, 3:
- sarcoidosis
- viral pneumonia
- pulmonary oedema - changes are commonly bilateral and often have a gravitational distribution
- radiation pneumonitis
- lymphocytic interstitial pneumonitis (LIP)
-<p><strong>Lymphangitic carcinomatosis</strong>, or <strong>lymphangitis carcinomatosa</strong>, is the term given to tumour spread through the lymphatics of the <a href="/articles/lung">lung</a>, and is most commonly seen secondary to adenocarcinoma.</p><h4>Epidemiology</h4><p>The demographics will reflect that of the underlying malignancy (see below).</p><h4>Clinical presentation</h4><p>Clinical presentation is variable. Some patients experience dyspnoea and abnormal pulmonary function tests early in the course of the disease, well before any radiographic abnormalities are evident, whereas others remain asymptomatic until much later <sup>4</sup>.</p><h4>Pathology</h4><p>Lymphangitis carcinomatosa is most commonly seen secondary to adenocarcinomas such as:</p><ul>- +<p><strong>Lymphangitic carcinomatosis</strong>, or <strong>lymphangitis carcinomatosa</strong>, is the term given to tumour spread through the lymphatics of the <a href="/articles/lung">lung</a> and is most commonly seen secondary to adenocarcinoma.</p><h4>Epidemiology</h4><p>The demographics will reflect that of the underlying malignancy (see below).</p><h4>Clinical presentation</h4><p>Clinical presentation is variable. Some patients experience dyspnoea and abnormal pulmonary function tests early in the course of the disease, well before any radiographic abnormalities are evident, whereas others remain asymptomatic until much later <sup>4</sup>.</p><h4>Pathology</h4><p>Lymphangitic carcinomatosis is most commonly seen secondary to adenocarcinomas such as:</p><ul>
-</ul><p>It can also be seen in numerous other primary cancers, e.g. <a href="/articles/laryngeal-cancer">laryngeal cancer</a>, <a href="/articles/pancreatic-neoplasms">pancreatic cancer</a>, etc. </p><p>A helpful <a href="/articles/lymphangitic-carcinomatosis-mnemonic">mnemonic for lymphangitic carcinomatosis</a> is sometimes used for its common causes.</p><h5>Mechanism</h5><p>Spread into the lymphatics in most cases (except in bronchogenic adenocarcinoma) usually occurs following haematogenous seeding of the lungs, with subsequent lymphatic involvement <sup>1, 3</sup>. It may also occur by retrograde spread into lymphatics from the mediastinal and hilar lymph nodes. </p><p>Both the peripheral lymphatics coursing in the interlobular septa and beneath the pleura, and the central lymphatics coursing in the bronchovascular interstitium are involved <sup>2</sup>.</p><p>Histologically tumour is seen both within lymphatics and in the adjacent interstitium, with associated oedema and desmoplasia <sup>3, 4</sup>.</p><h4>Radiographic features</h4><p>Radiographic appearances can most easily be divided into those due to the involvement of the peripheral (<a href="/articles/interlobular-septa">interlobular septae</a>) and central lymphatic system. Involvement may be diffusely of both, or predominantly of one or other compartment <sup>4</sup>. Distribution of changes is variable, but most are asymmetric and patchy <sup>3</sup>. It is usually bilateral but may be unilateral especially in cases of lung and breast cancer.</p><h5>Plain radiograph</h5><p>Unfortunately up to a quarter of patients with subsequently established lymphangitic carcinomatosis have normal chest x-rays <sup>2</sup>. When abnormal the most common finding is of a reticulonodular pattern, with <a href="/articles/interlobular-septal-thickening">thickening of the interlobular septae</a> which may resemble <a href="/articles/septal-lines-in-lung">Kerley B lines</a>.</p><h5>CT</h5><p>CT, especially HRCT, is excellent at demonstrating both peripheral and central changes.</p><p>Typically the appearance is that of <a href="/articles/interlobular-septal-thickening">interlobular septal thickening</a> most often nodular and irregular, although smooth thickening may also sometimes be seen <sup>1-4</sup>. This results in a prominent definition of the secondary pulmonary lobules, manifesting as tessellating polygons. </p><p><a href="/articles/thickening-of-the-bronchovascular-interstitium">Thickening of the bronchovascular interstitium</a> is usually irregular and nodular, with changes seen extending towards the hilum <sup>4</sup>. </p><p>The combination may give a characteristic "<a href="/articles/dot-in-box-appearance">dot in box</a>" appearance.</p><p>Additional HRCT findings include <sup>2, 4</sup>:</p><ul>- +</ul><p>It can also be seen in numerous other primary cancers, e.g. <a href="/articles/laryngeal-cancer">laryngeal cancer</a>, <a href="/articles/pancreatic-neoplasms">pancreatic cancer</a>, etc. </p><p>A helpful <a href="/articles/lymphangitic-carcinomatosis-mnemonic">mnemonic for lymphangitic carcinomatosis</a> is sometimes used for its common causes.</p><h5>Mechanism</h5><p>Spread into the lymphatics in most cases (except in bronchogenic adenocarcinoma) usually occurs following haematogenous seeding of the lungs, with subsequent lymphatic involvement <sup>1,3</sup>. It may also occur by retrograde spread into the lymphatics from the mediastinal and hilar lymph nodes.</p><p>Both the peripheral lymphatics coursing in the interlobular septa and beneath the pleura, and the central lymphatics coursing in the bronchovascular interstitium are involved <sup>2</sup>.</p><p>Histologically tumour is seen both within lymphatics and in the adjacent interstitium, with associated oedema and desmoplasia <sup>3,4</sup>.</p><h4>Radiographic features</h4><p>Radiographic appearances can most easily be divided into those due to the involvement of the peripheral (<a href="/articles/interlobular-septa">interlobular septae</a>) and central lymphatic system. Involvement may be diffusely of both, or predominantly of one compartment or the other <sup>4</sup>. Distribution of changes is variable, but most are asymmetric and patchy <sup>3</sup>. It is usually bilateral but may be unilateral, especially in cases of lung and breast cancer.</p><h5>Plain radiograph</h5><p>Unfortunately up to a quarter of patients with subsequently established lymphangitic carcinomatosis have normal chest x-rays <sup>2</sup>. When abnormal, the most common finding is a reticulonodular pattern, with <a href="/articles/interlobular-septal-thickening">thickening of the interlobular septae</a> which may resemble <a href="/articles/septal-lines-in-lung">Kerley B lines</a>.</p><h5>CT</h5><p>CT, especially HRCT, is excellent at demonstrating both peripheral and central changes.</p><p>Typically the appearance is that of <a href="/articles/interlobular-septal-thickening">interlobular septal thickening</a>, most often nodular and irregular, although smooth thickening may also sometimes be seen <sup>1-4</sup>. This results in a prominent definition of the secondary pulmonary lobules, manifesting as tessellating polygons.</p><p><a href="/articles/thickening-of-the-bronchovascular-interstitium">Thickening of the bronchovascular interstitium</a> is usually irregular and nodular, with changes seen extending towards the hilum <sup>4</sup>. </p><p>The combination may give a characteristic "<a href="/articles/dot-in-box-appearance">dot in box</a>" appearance.</p><p>Additional HRCT findings include <sup>2, 4</sup>:</p><ul>
-</ul><p>A helpful sign is that the overall lung and lobular architecture is preserved <sup>1</sup>. In most cases, lymphangitic carcinomatosis progresses rapidly and patients deteriorate (see treatment and prognosis below), however in some cases changes may remain stable over considerable time <sup>3</sup>. As such a 'stable' appearance when compared to previous imaging does not necessarily exclude the diagnosis.</p><h4>Treatment and prognosis</h4><p>Treatment is determined by the histology of the primary tumour, but in general, relies on systemic chemotherapy.</p><p>Prognosis of patients with lymphangitic carcinomatosis is poor, with approximately half of patients having succumbed to their illness within a year of diagnosis <sup>2, 3</sup>. Occasionally long term survival is encountered <sup>3</sup>.</p><h4>Differential diagnosis</h4><p>Considerations include a differential for that of <a href="/articles/interlobular-septal-thickening">thickened interlobular septae</a>, with common entities comprising of <sup>1, 3</sup>:</p><ul>- +</ul><p>A helpful sign is that the overall lung and lobular architecture is preserved <sup>1</sup>. In most cases, lymphangitic carcinomatosis progresses rapidly and patients deteriorate (see treatment and prognosis below), however in some cases changes may remain stable over considerable time <sup>3</sup>. As such a 'stable' appearance when compared to previous imaging does not necessarily exclude the diagnosis.</p><h4>Treatment and prognosis</h4><p>Treatment is determined by the histology of the primary tumour, but in general, relies on systemic chemotherapy.</p><p>Prognosis of patients with lymphangitic carcinomatosis is poor, with approximately half of patients succumbing to their illness within a year of diagnosis <sup>2, 3</sup>. Occasionally, long-term survival is encountered <sup>3</sup>.</p><h4>Differential diagnosis</h4><p>Considerations include a differential for that of <a href="/articles/interlobular-septal-thickening">thickened interlobular septae</a>, with common entities comprising of <sup>1, 3</sup>:</p><ul>
Unable to process the form. Check for errors and try again.